Adynovate recombinant and Mesalamine Controlled-Release Capsules
Determining the interaction of Adynovate recombinant and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate recombinant-Mesalamine Delayed Release Tablets
- Adynovate recombinant-Mesalamine Long-Acting Capsules (Apriso)
- Adynovate recombinant-Mesalamine Long-Acting Capsules (Delzicol)
- Adynovate recombinant-Mesalamine Long-Acting Capsules (Pentasa)
- Adynovate recombinant-Mesalamine rectal
- Adynovate recombinant-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-Adzenys ER
- Mesalamine Controlled-Release Capsules-Adzenys ER Oral Suspension
- Mesalamine Controlled-Release Capsules-Adzenys XR-ODT
- Mesalamine Controlled-Release Capsules-Aemcolo
- Mesalamine Controlled-Release Capsules-Aerobid
- Mesalamine Controlled-Release Capsules-Aerobid-M